Effect of dexmedetomidine on cerebral homeostasis in patients undergoing craniotomy for brain tumour excision: A randomized double‐blind trial
British Journal of Clinical Pharmacology · 2026
DOI: 10.1002/bcp.70606 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Clinical Pharmacology, 2026. Verfasst von Anastasia Nikopoulou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Dexmedetomidine, Craniotomy, Brain Neoplasms, Neuroprotective Agents. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Aim
Dexmedetomidine (DEX) seems to hold a potential neuroprotective role, possibly mediated by the attenuation of oxidative stress and neuroinflammation. This study aimed to delineate the effect of DEX used as an adjunct anaesthetic on cerebral oxygenation, cerebral injury and the release of inflammatory markers in brain tumour surgery.
Methods
Fifty‐six patients undergoing craniotomy for brain tumour excision were randomly assigned to receive either DEX (1 μg/kg for 10 min and thereafter 0.7 μg/kg/h) or placebo. Arterial and jugular‐bulb blood samples were collected at predefined time‐points, whereas a concomitant hemodynamic profile was obtained intraoperatively. S100B protein, neuron‐specific enolase (NSE), tumour necrosis factor‐α (TNF‐α), interleukin‐6 (IL‐6) and cortisol levels were determined at baseline and 6 and 24 h postoperatively.
Results
Demographic and perioperative characteristics were comparable between groups. Propofol consumption was considerably reduced in DEX‐treated patients ( p < 0.001). Measured (jugular‐bulb oxygen saturation and partial pressure of oxygen) and estimated (oxygen and carbon dioxide arterial‐jugular differences, brain oxygen extraction ratio) cerebral oxygenation indices were favourably affected by DEX infusion ( p < 0.05), yet this effect was valid for 15 min ( p < 0.05), corresponding to transient systemic hemodynamic augmentation. Moreover, postoperative S100B, NSE, TNF‐α, IL‐6 and cortisol levels were significantly attenuated in the DEX group ( p < 0.01).
Conclusion
DEX may attenuate the release of cerebral injury and neuroinflammation biomarkers and transiently improve hemodynamics and cerebral oxygenation during brain tumour surgery. Nonetheless, these surrogate effects do not establish clinically relevant neuroprotection, and potential dose‐related hemodynamic instability warrants cautious, individualized use.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Critical Care, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece.
- 1st Department of Microbiology, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece.
- Laboratory of Clinical Pharmacology, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece.
- Department of Neurosurgery, Aristotle University of Thessaloniki, School of Medicine, Thessaloniki, Greece.
ORCID-Profile: Anastasia Nikopoulou
Zitieren
APA
Nikopoulou, A., Grosomanidis, V., Poulopoulou, A., Vyzantiadis, T. A., Pourzitaki, C., Patsalas, I., & Tsaousi, G. G. (2026). Effect of dexmedetomidine on cerebral homeostasis in patients undergoing craniotomy for brain tumour excision: A randomized double‐blind trial. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70606
Vancouver
Nikopoulou A, Grosomanidis V, Poulopoulou A, Vyzantiadis TA, Pourzitaki C, Patsalas I, et al. Effect of dexmedetomidine on cerebral homeostasis in patients undergoing craniotomy for brain tumour excision: A randomized double‐blind trial. British Journal of Clinical Pharmacology. 2026. doi:10.1002/bcp.70606
BibTeX
@article{Nikopoulou2026,
author = {Nikopoulou, Anastasia and Grosomanidis, Vasileios and Poulopoulou, Aikaterina and Vyzantiadis, Timoleon-Achilleas and Pourzitaki, Chryssa and Patsalas, Ioannis and Tsaousi, Georgia G},
title = {Effect of dexmedetomidine on cerebral homeostasis in patients undergoing craniotomy for brain tumour excision: A randomized double‐blind trial},
journal = {British Journal of Clinical Pharmacology},
year = {2026},
doi = {10.1002/bcp.70606}
}
EUVIMED